quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:27:46·227d
INSIDERFiling
Foot Locker Inc. logo

Director Payne Ulice Jr returned 39,821 shares to the company, closing all direct ownership in the company (SEC Form 4)

FL· Foot Locker Inc.
Consumer Discretionary
Original source

Companies

  • FL
    Foot Locker Inc.
    Consumer Discretionary

Recent analyst ratings

  • Mar 3UpdateEvercore ISI$22.00
  • Jan 24UpdateNeedham$24.00
  • Dec 5UpdateTelsey Advisory Group$24.00
  • Nov 22UpdateNeedham$27.00
  • Oct 7UpdateGordon Haskett$27.00
  • Aug 29UpdateTelsey Advisory Group$30.00

Related

  • SEC217d
    SEC Form 15-12G filed by Foot Locker Inc.
  • INSIDER227d
    Director Underhill Kimberly K returned 41,993 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER227d
    Non-Executive Chair Young Dona D returned 143,799 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER227d
    Director Syngal Sonia returned 6,915 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER227d
    EVP, Chief Operations Officer Rodgers Elliott was granted 97,234 shares and returned 210,741 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER227d
    Director Walker Tristan returned 31,391 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER227d
    CEO Dillon Mary N was granted 739,813 shares and returned 1,262,240 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER227d
    SVP & Chief Accounting Officer Cipriano Giovanna was granted 31,231 shares and returned 128,533 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022